Discover how measurable residual disease (MRD) is transforming the treatment landscape in multiple myeloma. In this video, we explore how MRD testing is being used as a powerful guide to personalize therapy, measure treatment response, and shape the future of precision immunotherapy. Learn how advanced MRD detection techniques help doctors identify even tiny amounts of remaining myeloma cells, enabling more informed decisions about treatment intensity, duration, and next steps.


Recorded at the HealthTree Multiple Myeloma RoundTable in Miami, Ola Landgren, MD, discusses innovations in Myeloma treatment using precision immunotherapy.

If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/6286...

For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!

Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_so...
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.